Connection

Daniel Reuben to Cross-Over Studies

Back to Details
This is a "connection" page, showing publications Daniel Reuben has written about Cross-Over Studies.
Daniel Reuben
Connection Strength
0.044
Cross-Over Studies
  1. A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer. 2021 03 15; 127(6):894-904.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.